185 related articles for article (PubMed ID: 16448987)
1. How to best define the metabolic syndrome.
Magliano DJ; Shaw JE; Zimmet PZ
Ann Med; 2006; 38(1):34-41. PubMed ID: 16448987
[TBL] [Abstract][Full Text] [Related]
2. The metabolic syndrome: a global public health problem and a new definition.
Zimmet P; Magliano D; Matsuzawa Y; Alberti G; Shaw J
J Atheroscler Thromb; 2005; 12(6):295-300. PubMed ID: 16394610
[TBL] [Abstract][Full Text] [Related]
3. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study.
Hanley AJ; Karter AJ; Williams K; Festa A; D'Agostino RB; Wagenknecht LE; Haffner SM
Circulation; 2005 Dec; 112(24):3713-21. PubMed ID: 16344402
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
[TBL] [Abstract][Full Text] [Related]
5. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
[TBL] [Abstract][Full Text] [Related]
6. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
[TBL] [Abstract][Full Text] [Related]
8. The metabolic syndrome and risk of cardiovascular disease and diabetes: experiences with the new diagnostic criteria from the International Diabetes Federation.
Saely CH; Rein P; Drexel H
Horm Metab Res; 2007 Sep; 39(9):642-50. PubMed ID: 17846971
[TBL] [Abstract][Full Text] [Related]
9. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions.
Nilsson PM; Engström G; Hedblad B
Diabet Med; 2007 May; 24(5):464-72. PubMed ID: 17381496
[TBL] [Abstract][Full Text] [Related]
10. The metabolic syndrome: mechanisms, epidemiology, and clinical implications.
Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):17-27. PubMed ID: 19667650
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.
Choi KM; Kim SM; Kim YE; Choi DS; Baik SH; Lee J;
Metabolism; 2007 Apr; 56(4):552-8. PubMed ID: 17379016
[TBL] [Abstract][Full Text] [Related]
12. The metabolic syndrome and cardiovascular disease.
Bonora E
Ann Med; 2006; 38(1):64-80. PubMed ID: 16448990
[TBL] [Abstract][Full Text] [Related]
13. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
[TBL] [Abstract][Full Text] [Related]
15. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.
Hildrum B; Mykletun A; Hole T; Midthjell K; Dahl AA
BMC Public Health; 2007 Aug; 7():220. PubMed ID: 17727697
[TBL] [Abstract][Full Text] [Related]
16. The metabolic syndrome and cardiovascular risk: implications for clinical practice.
Eddy DM; Schlessinger L; Heikes K
Int J Obes (Lond); 2008 May; 32 Suppl 2():S5-10. PubMed ID: 18469838
[TBL] [Abstract][Full Text] [Related]
17. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of the metabolic syndrome among Korean adults using the new International Diabetes Federation definition and the new abdominal obesity criteria for the Korean people.
Kim HM; Kim DJ; Jung IH; Park C; Park J
Diabetes Res Clin Pract; 2007 Jul; 77(1):99-106. PubMed ID: 17118477
[TBL] [Abstract][Full Text] [Related]
19. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
Lorenzo C; Williams K; Hunt KJ; Haffner SM
Diabetes Care; 2007 Jan; 30(1):8-13. PubMed ID: 17192325
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
